Gershenson DM - Search Results

1

Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas.

Tone AA, McConechy MK, Yang W, Ding J, Yip S, Kong E, Wong KK, Gershenson DM, Mackay H, Shah S, Gilks B, Tinker AV, Clarke B, McAlpine JN, Huntsman D. Tone AA, et al. Among authors: gershenson dm. BMC Cancer. 2014 Dec 18;14:982. doi: 10.1186/1471-2407-14-982. BMC Cancer. 2014. PMID: 25523272 Free PMC article.

2

Transitional cell carcinoma in high-grade high-stage ovarian carcinoma. An indicator of favorable response to chemotherapy.

Robey SS, Silva EG, Gershenson DM, McLemore D, el-Naggar A, Ordonez NG. Robey SS, et al. Among authors: gershenson dm. Cancer. 1989 Mar 1;63(5):839-47. doi: 10.1002/1097-0142(19890301)63:5<839::aid-cncr2820630508>3.0.co;2-u. Cancer. 1989. PMID: 2644014

3

Ovarian serous borderline tumors with invasive peritoneal implants.

Gershenson DM, Silva EG, Levy L, Burke TW, Wolf JK, Tornos C. Gershenson DM, et al. Cancer. 1998 Mar 15;82(6):1096-103. Cancer. 1998. PMID: 9506355

4

Significantly greater expression of ER, PR, and ECAD in advanced-stage low-grade ovarian serous carcinoma as revealed by immunohistochemical analysis.

Wong KK, Lu KH, Malpica A, Bodurka DC, Shvartsman HS, Schmandt RE, Thornton AD, Deavers MT, Silva EG, Gershenson DM. Wong KK, et al. Among authors: gershenson dm. Int J Gynecol Pathol. 2007 Oct;26(4):404-9. doi: 10.1097/pgp.0b013e31803025cd. Int J Gynecol Pathol. 2007. PMID: 17885490

5

The continuum of serous tumors of low malignant potential and low-grade serous carcinomas of the ovary.

Wong KK, Gershenson D. Wong KK, et al. Dis Markers. 2007;23(5-6):377-87. doi: 10.1155/2007/204715. Dis Markers. 2007. PMID: 18057521 Free PMC article. Review.

6

PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas.

Tung CS, Mok SC, Tsang YT, Zu Z, Song H, Liu J, Deavers MT, Malpica A, Wolf JK, Lu KH, Gershenson DM, Wong KK. Tung CS, et al. Among authors: gershenson dm. Mod Pathol. 2009 Sep;22(9):1243-50. doi: 10.1038/modpathol.2009.92. Epub 2009 Jun 12. Mod Pathol. 2009. PMID: 19525924 Free PMC article.

7

BRAF mutation is rare in advanced-stage low-grade ovarian serous carcinomas.

Wong KK, Tsang YT, Deavers MT, Mok SC, Zu Z, Sun C, Malpica A, Wolf JK, Lu KH, Gershenson DM. Wong KK, et al. Among authors: gershenson dm. Am J Pathol. 2010 Oct;177(4):1611-7. doi: 10.2353/ajpath.2010.100212. Epub 2010 Aug 27. Am J Pathol. 2010. PMID: 20802181 Free PMC article.

8

Clinicodemographic factors influencing outcomes in patients with low-grade serous ovarian carcinoma.

Schlumbrecht MP, Sun CC, Wong KN, Broaddus RR, Gershenson DM, Bodurka DC. Schlumbrecht MP, et al. Among authors: gershenson dm. Cancer. 2011 Aug 15;117(16):3741-9. doi: 10.1002/cncr.25929. Epub 2011 Feb 11. Cancer. 2011. PMID: 21319148 Free PMC article.

9

The anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian cancer.

King ER, Tung CS, Tsang YT, Zu Z, Lok GT, Deavers MT, Malpica A, Wolf JK, Lu KH, Birrer MJ, Mok SC, Gershenson DM, Wong KK. King ER, et al. Among authors: gershenson dm. Am J Surg Pathol. 2011 Jun;35(6):904-12. doi: 10.1097/PAS.0b013e318212ae22. Am J Surg Pathol. 2011. PMID: 21451362 Free PMC article.

10

The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinoma.

King ER, Zu Z, Tsang YT, Deavers MT, Malpica A, Mok SC, Gershenson DM, Wong KK. King ER, et al. Among authors: gershenson dm. Gynecol Oncol. 2011 Oct;123(1):13-8. doi: 10.1016/j.ygyno.2011.06.016. Epub 2011 Jul 2. Gynecol Oncol. 2011. PMID: 21726895 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

508 results

Search Page